CA2342957A1 - Proteine regulatrice issue de keratinocytes humains - Google Patents

Proteine regulatrice issue de keratinocytes humains Download PDF

Info

Publication number
CA2342957A1
CA2342957A1 CA002342957A CA2342957A CA2342957A1 CA 2342957 A1 CA2342957 A1 CA 2342957A1 CA 002342957 A CA002342957 A CA 002342957A CA 2342957 A CA2342957 A CA 2342957A CA 2342957 A1 CA2342957 A1 CA 2342957A1
Authority
CA
Canada
Prior art keywords
seq
protein
sequence
nucleic acid
pke
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342957A
Other languages
English (en)
Inventor
Michael Kramer
Michael Bechtel
Jeanette Reinartz
Birgit Schafer
Reinhard Wallich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342957A1 publication Critical patent/CA2342957A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un polypeptide isolé qui est équivalent ou similaire (en termes de fonction et d'effet) à une protéine intervenant de manière naturelle dans des kératinocytes humains et qui est amplifiée à l'état actif des kératinocytes. L'invention concerne en outre un acide nucléique isolé qui code un polypeptide ou une protéine typique des kératinocytes humains. L'invention concerne par ailleurs l'utilisation de ce polypeptide et de cet acide nucléique à des fins d'analyse, notamment à des fins de diagnostic, et/ou à des fins thérapeutiques. L'invention concerne également l'utilisation de réactifs, notamment de molécules vecteurs et d'anticorps, à l'encontre de molécules de ce type. L'invention obtenue selon l'invention présente soit un protocole séquentiel SEQ ID NO:2, soit la séquence d'aminoacide présentée dans le protocole séquentiel SEQ ID NO:3, soit un allèle ou un dérivé de cette séquence d'aminoacide, apparu par substitution, suppression, insertion ou inversion d'aminoacide. L'acide nucléique de l'invention présente soit la séquence nucléotide figurant dans le protocole séquentiel SEQ ID NO:1, soit la séquence nucléotide figurant dans le protocole séquentiel SEQ ID NO:4, soit une séquence nucléotide qui en est complémentaire, soit une séquence nucléotide hybridisée en totalité ou en partie avec une des séquences nucléotides précitées.
CA002342957A 1998-09-19 1999-09-06 Proteine regulatrice issue de keratinocytes humains Abandoned CA2342957A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19842863.4 1998-09-19
DE19842863A DE19842863A1 (de) 1998-09-19 1998-09-19 Regulatorisches Protein aus humanen Keratinozyten
PCT/DE1999/002865 WO2000017232A2 (fr) 1998-09-19 1999-09-06 Proteine regulatrice issue de keratinocytes humains

Publications (1)

Publication Number Publication Date
CA2342957A1 true CA2342957A1 (fr) 2000-03-30

Family

ID=7881448

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342957A Abandoned CA2342957A1 (fr) 1998-09-19 1999-09-06 Proteine regulatrice issue de keratinocytes humains

Country Status (6)

Country Link
EP (1) EP1114157A2 (fr)
JP (1) JP2002526060A (fr)
AU (1) AU1149100A (fr)
CA (1) CA2342957A1 (fr)
DE (2) DE19842863A1 (fr)
WO (1) WO2000017232A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240194A2 (fr) * 1999-11-24 2002-09-18 Sugen, Inc. Nouvelles proteines kinases humaines et enzymes analogues
AU2001245974A1 (en) * 2000-03-24 2001-10-08 Millennium Pharmaceuticals, Inc. 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
GB0400122D0 (en) * 2004-01-06 2004-02-11 Badrilla Ltd Method of quantifying binding
US6946028B1 (en) * 2004-09-07 2005-09-20 Kerr-Mcgee Chemical Llc Surface-treated pigments
JP2015072226A (ja) * 2013-10-03 2015-04-16 住友ベークライト株式会社 検査方法

Also Published As

Publication number Publication date
DE19842863A1 (de) 2000-04-27
EP1114157A2 (fr) 2001-07-11
JP2002526060A (ja) 2002-08-20
AU1149100A (en) 2000-04-10
DE19981873D2 (de) 2002-01-24
WO2000017232A2 (fr) 2000-03-30
WO2000017232A3 (fr) 2000-10-12

Similar Documents

Publication Publication Date Title
Appel et al. Several extracellular domains of the neural cell adhesion molecule L1 are involved in neurite outgrowth and cell body adhesion
DeLuca-Flaherty et al. Uncoating protein (hsc70) binds a conformationally labile domain of clathrin light chain LCa to stimulate ATP hydrolysis
Miyata et al. Interaction between casein kinase II and the 90-kDa stress protein, HSP90
Dornreiter et al. SV40 T antigen binds directly to the large subunit of purified DNA polymerase alpha.
Xiong et al. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
JP2986548B2 (ja) 腫瘍タンパク質のプロテインキナーゼ
CA2146965C (fr) Rearrangement complexe de cycline et utilisations connexes
CA2183961A1 (fr) Facteur-10 codant la croissance de fibroblastes
US6391574B1 (en) AFC1 and RCE1: isoprenylated CAAX processing enzymes
JPH10510422A (ja) チロシンリン酸化タンパク質に結合する新規なタンパク質ドメイン
AU2001263952B2 (en) Tumour suppressor and uses thereof
US6280955B1 (en) Interleukin-1 receptor accessory proteins, nucleic acids and methods
ES2249774T3 (es) Proteinas serina/tronina quinasas nucleares.
US5905146A (en) DNA binding protein S1-3
CA2342957A1 (fr) Proteine regulatrice issue de keratinocytes humains
Chain et al. Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which ‘buries’ Ser-378, its site of phosphorylation by protein kinase A
AU645243B2 (en) Human heat shock factor
JP2002534087A (ja) 単球由来核酸および関連する組成物ならびに方法
US5646249A (en) Isolation and characterization of a novel chaperone protein
JP2002518008A (ja) アンジオスタチン結合性タンパク質
JPH10201491A (ja) タンパク質ホスファターゼ１結合タンパク質ｒ５
US20070154911A1 (en) Regulatory protein pke#83 from human keratinocytes
US6753413B1 (en) P35NCK5A binding proteins
US6297019B1 (en) Recombinant polynucleotides encoding CYP7 promoter-binding factors
JP2001501802A (ja) ハンチンチン（ｈｕｎｔｉｎｇｔｉｎ）結合蛋白質

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead